Alcon Provides Documents In Philadelphia PBM Investigation
Executive Summary
PBM switch campaigns for ophthalmic drugs may be an area of interest in the federal investigation of pharmaceutical benefit management practices.
You may also be interested in...
Allergan Acular Generic Defense Subject Of FTC Investigation, Apotex Lawsuit
Allergan's exclusivity defense for Acular (ketorolac ophthalmic solution) is the subject of a Federal Trade Commission investigation
Allergan Acular Generic Defense Subject Of FTC Investigation, Apotex Lawsuit
Allergan's exclusivity defense for Acular (ketorolac ophthalmic solution) is the subject of a Federal Trade Commission investigation
ADR Cases Could Be Prosecuted Under Kickback Statute – U.S. Atty Sheehan
The federal anti-kickback statute is broad enough to allow prosecution of pharmaceutical manufacturers for inadequate reporting of adverse events, Philadelphia Assistant U.S. Attorney James Sheehan maintained during a Food & Drug Law Institute meeting Sept. 12 in Washington, D.C